Works about HAND-foot syndrome

Results: 655
    1
    2
    3
    4
    5
    6

    Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study.

    Published in:
    Oncology, 2017, v. 93, p. 113, doi. 10.1159/000481241
    By:
    • Ogawa, Chikara;
    • Morita, Masahiro;
    • Omura, akina;
    • Noda, Teruyo;
    • Kubo, atsushi;
    • Matsunaka, Toshihiro;
    • Tamaki, Hiroyuki;
    • Shibatoge, Mitsushige;
    • Tsutsui, akemi;
    • Senoh, Tomonori;
    • Nagano, Takuya;
    • Takaguchi, Kouichi;
    • Tani, Joji;
    • Morishita, asahiro;
    • Yoneyama, Hirohito;
    • Masaki, Tsutomu;
    • Moriya, akio;
    • ando, Masaharu;
    • Deguchi, akihiro;
    • Kokudo, Yasutaka
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2.

    Published in:
    Oncologist, 2025, v. 30, n. 3, p. 1, doi. 10.1093/oncolo/oyae360
    By:
    • Eng, Cathy;
    • Dasari, Arvind;
    • Lonardi, Sara;
    • Garcia-Carbonero, Rocio;
    • Elez, Elena;
    • Yoshino, Takayuki;
    • Sobrero, Alberto;
    • Yao, James;
    • Garcia-Alfonso, Pilar;
    • Kocsis, Judit;
    • Gracian, Antonio Cubillo;
    • Sartore-Bianchi, Andrea;
    • Satoh, Taroh;
    • Randrian, Violaine;
    • Tomasek, Jiri;
    • Chong, Geoff;
    • Yang, Zhao;
    • Guevara, Ferdinand;
    • Schelman, William;
    • Pallai, Rajash
    Publication type:
    Article
    15
    16
    17
    18
    19

    Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703).

    Published in:
    Oncologist, 2021, v. 26, n. 10, p. e1693, doi. 10.1002/onco.13857
    By:
    • Chi, Yihebali;
    • Shu, Yongqian;
    • Ba, Yi;
    • Bai, Yuxian;
    • Qin, Baoli;
    • Wang, Xiuwen;
    • Xiong, Jianping;
    • Xu, Nong;
    • Zhang, Helong;
    • Zhou, Jianfeng;
    • Xu, Jianming;
    • Cheng, Ying;
    • Feng, Jifeng;
    • Hu, Chunhong;
    • Chen, Yigui;
    • Chen, Zhendong;
    • Wang, Jufeng;
    • Dang, Chengxue;
    • Wang, Jianhong;
    • Wan, Yiye
    Publication type:
    Article
    20

    Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial.

    Published in:
    Oncologist, 2021, v. 26, n. 7, p. 610, doi. 10.1002/onco.13730
    By:
    • Jatoi, Aminah;
    • Ou, Fang‐Shu;
    • Ahn, Daniel H.;
    • Zemla, Tyler J.;
    • Le‐Rademacher, Jennifer G.;
    • Boland, Patrick;
    • Ciombor, Kristen K.;
    • Jacobs, Nisha L.;
    • Pasche, Boris;
    • Cleary, James M.;
    • McCune, Jeannine S.;
    • Pedersen, Katrina S.;
    • Barzi, Afsaneh;
    • Chiorean, E. Gabriela;
    • Heying, Erica N.;
    • Lenz, Heinz‐Josef;
    • Sloan, Jeff A.;
    • Grothey, Axel;
    • Lacouture, Mario E.;
    • Bekaii‐Saab, Tanios
    Publication type:
    Article
    21

    Effect of a Structured Teaching Module Including Intensive Prophylactic Measures on Reducing the Incidence of Capecitabine‐Induced Hand‐Foot Syndrome: Results of a Prospective Randomized Phase III Study.

    Published in:
    Oncologist, 2020, v. 25, n. 12, p. e1886, doi. 10.1634/theoncologist.2020-0698
    By:
    • Ostwal, Vikas;
    • Kapoor, Akhil;
    • Mandavkar, Sarika;
    • Chavan, Neeta;
    • Gupta, Tarachand;
    • Mirani, Jimmy;
    • Saklani, Avanish;
    • Desouza, Ashwin;
    • Murugan, Kalaivani;
    • Nashikkar, Chaitali;
    • Gupta, Sudeep;
    • Ramaswamy, Anant
    Publication type:
    Article
    22

    Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial.

    Published in:
    Oncologist, 2019, v. 24, n. 9, p. 1180, doi. 10.1634/theoncologist.2019-0067
    By:
    • Riechelmann, Rachel P.;
    • Leite, Luiz S.;
    • Bariani, Giovanni M.;
    • Glasberg, Joao;
    • Rivelli, Thomas G.;
    • da Fonseca, Leonardo Gomes;
    • Nebuloni, Daniela R.;
    • Braghiroli, Maria I.;
    • Queiroz, Marcelo A.;
    • Isejima, Alice M.;
    • Kappeler, Christian;
    • Kikuchi, Luciana;
    • Hoff, Paulo M.
    Publication type:
    Article
    23
    24
    25
    26

    Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study.

    Published in:
    Oncologist, 2019, v. 24, n. 2, p. 185, doi. 10.1634/theoncologist.2018-0072
    By:
    • Van Cutsem, Eric;
    • Martinelli, Erika;
    • Cascinu, Stefano;
    • Sobrero, Alberto;
    • Banzi, Maria;
    • Seitz, Jean‐François;
    • Barone, Carlo;
    • Ychou, Marc;
    • Peeters, Marc;
    • Brenner, Baruch;
    • Hofheinz, Ralf Dieter;
    • Maiello, Evaristo;
    • André, Thierry;
    • Spallanzani, Andrea;
    • Garcia‐Carbonero, Rocio;
    • Arriaga, Yull E.;
    • Verma, Udit;
    • Grothey, Axel;
    • Kappeler, Christian;
    • Miriyala, Ashok
    Publication type:
    Article
    27
    28
    29
    30
    31

    What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
    By:
    • Atsushi Hiraoka;
    • Takashi Kumada;
    • Toshifumi Tada;
    • Kazuya Kariyama;
    • Joji Tani;
    • Shinya Fukunishi;
    • Masanori Atsukawa;
    • Masashi Hirooka;
    • Kunihiko Tsuji;
    • Toru Ishikawa;
    • Koichi Takaguchi;
    • Ei Itobayashi;
    • Kazuto Tajiri;
    • Noritomo Shimada;
    • Hiroshi Shibata;
    • Hironori Ochi;
    • Kazuhito Kawata;
    • Satoshi Yasuda;
    • Hidenori Toyoda;
    • Hideko Ohama
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01).

    Published in:
    Cancer Research & Treatment, 2019, v. 51, n. 1, p. 43, doi. 10.4143/crt.2017.562
    By:
    • In Hae Park;
    • Seock-Ah Im;
    • Kyung Hae Jung;
    • Joo Hyuk Sohn;
    • Yeon Hee Park;
    • Keun Seok Lee;
    • Sung Hoon Sim;
    • Kyong-Hwa Park;
    • Jee Hyun Kim;
    • Byung Ho Nam;
    • Hee-Jun Kim;
    • Tae-Yong Kim;
    • Kyung-Hun Lee;
    • Sung-Bae Kim;
    • Jin-Hee Ahn;
    • Suee Lee;
    • Jungsil Ro
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50